These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 34997970)
1. LncRNA LINC00924 upregulates NDRG2 to inhibit epithelial-mesenchymal transition via sponging miR-6755-5p in hepatitis B virus-related hepatocellular carcinoma. Yu K; Mei Y; Wang Z; Liu B; Deng M J Med Virol; 2022 Jun; 94(6):2702-2713. PubMed ID: 34997970 [TBL] [Abstract][Full Text] [Related]
2. Long Noncoding RNA Gong X; Zhu Z Cancer Biother Radiopharm; 2020 Jun; 35(5):387-396. PubMed ID: 32315535 [No Abstract] [Full Text] [Related]
3. Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma. Liu Z; Wang Y; Wang L; Yao B; Sun L; Liu R; Chen T; Niu Y; Tu K; Liu Q J Exp Clin Cancer Res; 2019 May; 38(1):194. PubMed ID: 31088485 [TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA F11-AS1 inhibits HBV-related hepatocellular carcinoma progression by regulating NR1I3 via binding to microRNA-211-5p. Deng Y; Wei Z; Huang M; Xu G; Wei W; Peng B; Nong S; Qin H J Cell Mol Med; 2020 Jan; 24(2):1848-1865. PubMed ID: 31880390 [TBL] [Abstract][Full Text] [Related]
5. The long noncoding RNA AK002107 negatively modulates miR-140-5p and targets TGFBR1 to induce epithelial-mesenchymal transition in hepatocellular carcinoma. Tang YH; He GL; Huang SZ; Zhong KB; Liao H; Cai L; Gao Y; Peng ZW; Fu SJ Mol Oncol; 2019 May; 13(5):1296-1310. PubMed ID: 30943320 [TBL] [Abstract][Full Text] [Related]
6. TGF-β1-Induced LINC01094 promotes epithelial-mesenchymal transition in hepatocellular carcinoma through the miR-122-5p/TGFBR2-SAMD2-SMAD3 Axis. Yang X; Xu C; Liu C; Wu X; Chen X; Hou J; Wang L Funct Integr Genomics; 2024 Jul; 24(4):123. PubMed ID: 38992207 [TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis. Wang Y; Liu Z; Yao B; Li Q; Wang L; Wang C; Dou C; Xu M; Liu Q; Tu K Mol Cancer; 2017 Jul; 16(1):123. PubMed ID: 28716020 [TBL] [Abstract][Full Text] [Related]
8. CASC15 promotes epithelial to mesenchymal transition and facilitates malignancy of hepatocellular carcinoma cells by increasing TWIST1 gene expression via miR-33a-5p sponging. Li Y; Chen G; Yan Y; Fan Q Eur J Pharmacol; 2019 Oct; 860():172589. PubMed ID: 31401158 [TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA Unigene56159 promotes epithelial-mesenchymal transition by acting as a ceRNA of miR-140-5p in hepatocellular carcinoma cells. Lv J; Fan HX; Zhao XP; Lv P; Fan JY; Zhang Y; Liu M; Tang H Cancer Lett; 2016 Nov; 382(2):166-175. PubMed ID: 27597739 [TBL] [Abstract][Full Text] [Related]
10. LncRNA NUTM2A-AS1 aggravates the progression of hepatocellular carcinoma by activating the miR-186-5p/KLF7-mediated Wnt/beta-catenin pathway. Long J; Liu L; Yang X; Zhou X; Lu X; Qin L Hum Cell; 2023 Jan; 36(1):312-328. PubMed ID: 36242728 [TBL] [Abstract][Full Text] [Related]
11. lncRNA-POIR promotes epithelial-mesenchymal transition and suppresses sorafenib sensitivity simultaneously in hepatocellular carcinoma by sponging miR-182-5p. Chen BW; Zhou Y; Wei T; Wen L; Zhang YB; Shen SC; Zhang J; Ma T; Chen W; Ni L; Wang Y; Bai XL; Liang TB J Cell Biochem; 2021 Jan; 122(1):130-142. PubMed ID: 32951268 [TBL] [Abstract][Full Text] [Related]
12. LncRNA DARS-AS1 aggravates the growth and metastasis of hepatocellular carcinoma via regulating the miR-3200-5p-Cytoskeleton associated protein 2 (CKAP2) axis. Feng Y; Wei G; Zhang L; Zhou H; Wang W; Guo P; Cheng C; Ji L; Cai Q; Feng Y; Tu H Bioengineered; 2021 Dec; 12(1):8217-8232. PubMed ID: 34596006 [TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway. Li Y; Liu G; Li X; Dong H; Xiao W; Lu S Biochem Biophys Res Commun; 2018 Sep; 503(4):2826-2832. PubMed ID: 30115383 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-98-5p Inhibits Tumorigenesis of Hepatitis B Virus-Related Hepatocellular Carcinoma by Targeting NF-κB-Inducing Kinase. Fei X; Zhang P; Pan Y; Liu Y Yonsei Med J; 2020 Jun; 61(6):460-470. PubMed ID: 32469170 [TBL] [Abstract][Full Text] [Related]
16. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway. Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392 [TBL] [Abstract][Full Text] [Related]
17. LncRNA SNHG12 promotes proliferation and epithelial mesenchymal transition in hepatocellular carcinoma through targeting HEG1 via miR-516a-5p. Chen PP; Zhang ZS; Wu JC; Zheng JF; Lin F Cell Signal; 2021 Aug; 84():109992. PubMed ID: 33774129 [TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA EPB41L4A-AS2 inhibits hepatocellular carcinoma development by sponging miR-301a-5p and targeting FOXL1. Wang YG; Wang T; Shi M; Zhai B J Exp Clin Cancer Res; 2019 Apr; 38(1):153. PubMed ID: 30971290 [TBL] [Abstract][Full Text] [Related]
19. LINC00922 promotes the proliferation, migration, invasion and EMT process of liver cancer cells by regulating miR-424-5p/ARK5. Ye Z; He Q; Wang Q; Lin Y; Cen K; Chen X Mol Cell Biochem; 2021 Oct; 476(10):3757-3769. PubMed ID: 34097192 [TBL] [Abstract][Full Text] [Related]
20. LncRNA n335586/miR-924/CKMT1A axis contributes to cell migration and invasion in hepatocellular carcinoma cells. Fan H; Lv P; Mu T; Zhao X; Liu Y; Feng Y; Lv J; Liu M; Tang H Cancer Lett; 2018 Aug; 429():89-99. PubMed ID: 29753758 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]